These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7671890)

  • 1. Relationship between HDL-cholesterol and apolipoprotein A1 and the severity of coronary artery disease.
    Garfagnini A; Devoto G; Rosselli P; Boggiano P; Venturini M
    Eur Heart J; 1995 Apr; 16(4):465-70. PubMed ID: 7671890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol. Predictive value for CHD severity and prognostic utility in CHD patients.
    Liting P; Guoping L; Zhenyue C
    Herz; 2015 Mar; 40 Suppl 1():1-7. PubMed ID: 25374385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Apolipoprotein B/A1 ratio, Framingham risk score and TC/HDL-c for predicting clinical outcomes in patients undergoing percutaneous coronary intervention.
    Tian M; Li R; Shan Z; Wang DW; Jiang J; Cui G
    Lipids Health Dis; 2019 Nov; 18(1):202. PubMed ID: 31744496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined use of apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol before routine clinical lipid measurement in predicting coronary heart disease.
    Pan L; Lu G; Chen Z
    Coron Artery Dis; 2014 Aug; 25(5):433-8. PubMed ID: 24608795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-HDL-cholesterol/HDL-cholesterol is a better predictor of metabolic syndrome and insulin resistance than apolipoprotein B/apolipoprotein A1.
    Kim SW; Jee JH; Kim HJ; Jin SM; Suh S; Bae JC; Kim SW; Chung JH; Min YK; Lee MS; Lee MK; Kim KW; Kim JH
    Int J Cardiol; 2013 Oct; 168(3):2678-83. PubMed ID: 23545148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein A1 gene polymorphisms and risk of early coronary disease.
    Reguero JR; Cubero GI; Batalla A; Alvarez V; Hevia S; Cortina A; Coto E
    Cardiology; 1998 Dec; 90(3):231-5. PubMed ID: 9892774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low serum apolipoprotein A1/B ratio is associated with proliferative diabetic retinopathy in type 2 diabetes.
    Hu A; Luo Y; Li T; Guo X; Ding X; Zhu X; Wang X; Tang S
    Graefes Arch Clin Exp Ophthalmol; 2012 Jul; 250(7):957-62. PubMed ID: 22327732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum apolipoprotein AI, B levels in patients with coronary diseases].
    He Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Aug; 18(4):217-9, 254. PubMed ID: 2128269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein B/A1 Ratio Is Associated with Severity of Coronary Artery Stenosis in CAD Patients but Not in Non-CAD Patients Undergoing Percutaneous Coronary Intervention.
    Hua R; Li Y; Li W; Wei Z; Yuan Z; Zhou J
    Dis Markers; 2021; 2021():8959019. PubMed ID: 34961824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Serum LDL-C and ApoB and SYNTAX Score in Patients With Stable Coronary Artery Disease.
    Lin T; Wang L; Guo J; Liu P; Chen L; Wei M; Li G
    Angiology; 2018 Sep; 69(8):724-729. PubMed ID: 29310455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of several single nucleotide polymorphisms and high body mass index on serum lipid traits.
    Yin RX; Wu DF; Miao L; Htet Aung LH; Cao XL; Yan TT; Long XJ; Liu WY; Zhang L; Li M
    Biofactors; 2013; 39(3):315-25. PubMed ID: 23355348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein A1 is a stronger prognostic marker than are HDL and LDL cholesterol for cardiovascular disease and mortality in elderly men.
    Florvall G; Basu S; Larsson A
    J Gerontol A Biol Sci Med Sci; 2006 Dec; 61(12):1262-6. PubMed ID: 17234819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities in the relationship of paraoxonase 1 with HDL and apolipoprotein A1 and their possible connection to HDL dysfunctionality in type 2 diabetes.
    Viktorinova A; Jurkovicova I; Fabryova L; Kinova S; Koren M; Stecova A; Svitekova K
    Diabetes Res Clin Pract; 2018 Jun; 140():174-182. PubMed ID: 29626583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The characteristics of high density lipoprotein cholesterol and the relationship between high density lipoprotein cholesterol and the severity of coronary artery lesions in young men with acute myocardial infarction].
    Li Z; Tao Y; Huang J; Wang Q; Zhang DH; Wu XY
    Zhonghua Yi Xue Za Zhi; 2013 May; 93(19):1458-62. PubMed ID: 24029567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ApoA1/HDL-C ratio as a predictor for coronary artery disease in patients with type 2 diabetes: a matched case-control study.
    Ghaemi F; Rabizadeh S; Yadegar A; Mohammadi F; Asadigandomani H; Bafrani MA; Reyhan SK; Esteghamati A; Nakhjavani M
    BMC Cardiovasc Disord; 2024 Jun; 24(1):317. PubMed ID: 38914982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
    Walldius G; Jungner I; Aastveit AH; Holme I; Furberg CD; Sniderman AD
    Clin Chem Lab Med; 2004; 42(12):1355-63. PubMed ID: 15576296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computationally estimated apolipoproteins B and A1 in predicting cardiovascular risk.
    Raitakari OT; Mäkinen VP; McQueen MJ; Niemi J; Juonala M; Jauhiainen M; Salomaa V; Hannuksela ML; Savolainen MJ; Kesäniemi YA; Kovanen PT; Sundvall J; Solakivi T; Loo BM; Marniemi J; Hernesniemi J; Lehtimäki T; Kähönen M; Peltonen M; Leiviskä J; Jula A; Anand SS; Miller R; Yusuf S; Viikari JS; Ala-Korpela M
    Atherosclerosis; 2013 Jan; 226(1):245-51. PubMed ID: 23159013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Value of the Apolipoprotein B/Apolipoprotein A1 Ratio in Predicting the Rapid Progression of Non-Culprit Coronary Lesions in Acute Coronary Syndrome in Patients with Diabetes Mellitus after Percutaneous Coronary Intervention.
    Zhou Y; Liu H; Yang H; Zhao X; Jiao Y
    Int Heart J; 2023 Jul; 64(4):562-569. PubMed ID: 37460319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Indicators of atherosclerosis risk. Evaluation with coronary angiography in non diabetic men with total cholesterol levels equal to or below 240 mg/dl].
    Arteaga A; Martínez A; Pollak F; Borghesi L; Catalán L; Acosta AM; Leighton F
    Rev Med Chil; 1995 Feb; 123(2):145-57. PubMed ID: 7569454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.